{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:15:36Z","timestamp":1793078136233,"version":"4.5.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:p>Arterial stiffness is an important determinant of cardiovascular risk. The precise risk factors for arterial stiffening remain unclear. We aimed to identify potential risk factors using prospective exposure data from the Caerphilly Prospective Study. Aortic pulse wave velocity and augmentation index were measured in 825 men and related to current (2004) and baseline (1979\u20131988) anthropometric, hemodynamic, and biochemical factors. The mean age of the men was 74 years, with an average follow-up of 20 years. The only independent baseline predictors of current velocity were pulse pressure (standardized \u03b2-coefficient: 0.58), C-reactive protein (0.35), glucose (0.25), and waist circumference (0.23). The sole baseline predictor of current augmentation index was fibrinogen (0.78). After additional adjustment for the corresponding current risk factor, pulse wave velocity was best related to cumulative exposure to C-reactive protein, whereas augmentation index was most strongly related to current levels. Velocity was also more strongly correlated with baseline levels of triglycerides and smoking but with current waist circumference. The pulse pressure heart rate product assessed over the whole of 20 years was independently correlated with aortic pulse wave velocity but not augmentation index. Other than blood pressure, established cardiovascular risk factors have only a modest effect on aortic stiffness and wave reflection. Inflammation and the level of repetitive cyclic stress are important predictors of aortic stiffness, whereas wave reflection is predicted by acute inflammation only. Adequate control of pulse pressure and heart rate, as well as reducing inflammation, may, in the long-term, retard aortic stiffening, although this remains to be tested directly.<\/jats:p>","DOI":"10.1161\/hypertensionaha.110.150896","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T20:57:36Z","timestamp":1275944256000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":181,"title":["An Analysis of Prospective Risk Factors for Aortic Stiffness in Men"],"prefix":"10.1161","volume":"56","author":[{"given":"Carmel M.","family":"McEniery","sequence":"first","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spratt","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Munnery","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Yarnell","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon D.","family":"Lowe","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Rumley","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gallacher","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Cockcroft","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"From the Clinical Pharmacology Unit (C.M.M., I.B.W.), University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, United Kingdom; Department of Social Medicine (M.S., Y.B.-S.), University of Bristol, Bristol, United Kingdom; Department of Cardiology (M.M., J.R.C.), Wales Heart Research Institute, Cardiff, United Kingdom; Department of Epidemiology and Public Health (J.Y.), Queen\u2019s University, Belfast, United Kingdom; Division of Cardiovascular and Medical Sciences (G.D.L., A.R.), University of..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_1_2","unstructured":"Nichols WW O'Rourke MF. McDonald\u2019s Blood Flow in Arteries: Theoretical Experimental and Clinical Principles. 5th ed. London United: Arnold; 2005."},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00586-0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.artres.2007.03.003"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.104.483628"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00932.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1976.tb03322.x"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2004.04074.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000164581.39811.bd"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.71.2.3965165"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.07.037"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.109.137653"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.96.1.308"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.10.1202"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.052"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/jech.38.3.259"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.105.557132"},{"key":"e_1_3_3_17_2","first-page":"55","volume":"1","year":"1996","unstructured":"O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit. 1996; 1: 55\u201361.","journal-title":"Blood Press Monit"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199602000-00001"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.38.4.932"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000223013.60612.72"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199816121-00033"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.1999.1982"},{"key":"e_1_3_3_23_2","unstructured":"Kirkood BR Sterne JAC. Regression modelling. In: Essential Medical Statistics. 2nd ed. Oxford United Kingdom: Blackwell Sciences Ltd; 2003."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.1.201"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","unstructured":"Wilkinson IB Cockcroft JR. Cholesterol lipids and arterial stiffness. In: Safar ME Frohlich ED eds. Atherosclerosis Large Arteries and Cardiovascular Risk. Basel Switzerland: Karger; 2007: 261\u2013277.","DOI":"10.1159\/000096747"},{"key":"e_1_3_3_26_2","doi-asserted-by":"crossref","unstructured":"Wilkinson IB Westerbacka J Yki-Jarvinen H Cockcroft JR. Diabetes and arterial stiffness. In: Johnstone MT Veves A eds. Diabetes and Cardiovascular Disease. Totowa NJ: Humana Press Inc; 2001: 343\u2013360.","DOI":"10.1007\/978-1-59259-091-9_18"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.7.6.572"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000047464.66901.60"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.zhq0504.0173"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000165313.84007.7d"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2004.12.016"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000165025.16381.44"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.107.090068"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200211000-00015"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00149831-200412000-00009"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00146267"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.04.006"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01723-0"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.03.730"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.22.2945"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.0000146691.51307.84"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.108.117622"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00732.2006"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.37.6.1429"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.2101"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715120-00009"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90666-1"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60602-9"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.110.150896","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:17:00Z","timestamp":1738811820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.110.150896"}},"subtitle":["20-Year Follow-Up From the Caerphilly Prospective Study"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.110.150896"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.110.150896","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"2010-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-02-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-05-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-06-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}